FindTrial
Sign In

Prognostic significance of lymph node status in head and neck cancer

The prognostic significance of lymph node ratio and log odds ratio in head and neck squamous cell carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/030125
Enrollment
125
Registered
2020-12-30
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

Intervention1: Not applicable as it is an observational study: Not applicable Control Intervention1: Nil as it is an observational study: nil

Sponsors

Dr Shama Shetty
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with biopsy proven head and neck squamous cell carcinoma who underwent curative surgery for the same

Exclusion criteria

Exclusion criteria: patients with synchronous or metachronous malignancies, recurrent tumours, unresectable disease, who had undergone treatment before referral institute or had incomplete pathological or follow up data, number of lymph nodes dissected less than 6, patients with distant metastases, patients with severe immunosuppression

Design outcomes

Primary

MeasureTime frame
overall survival disease free survivalTimepoint: all patients will be followed up for a period of 2 years—

Secondary

MeasureTime frame
risk stratification based on lymph node ratioTimepoint: all patients will be followed up for a period of 2 years—

Countries

India

Contacts

Public ContactDr Shama Shetty

Kasturba Medical College, Manipal

shama.shetty@manipal.edu

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026